학술논문
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
Document Type
Article
Author
Lee, Nancy Y ; Ferris, Robert L; Psyrri, Amanda; Haddad, Robert I; Tahara, Makoto; Bourhis, Jean; Harrington, Kevin; Chang, Peter Mu-Hsin; Lin, Jin-Ching; Razaq, Mohammad Abdul; Teixeira, Maria Margarida; Lövey, József; Chamois, Jerome; Rueda, Antonio; Hu, Chaosu; Dunn, Lara A; Dvorkin, Mikhail Vladimirovich; De Beukelaer, Steven; Pavlov, Dmitri; Thurm, Holger; Cohen, Ezra
Source
In The Lancet Oncology April 2021 22(4):450-462
Subject
Language
ISSN
1470-2045